These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28146436)

  • 1. Silence of cancer susceptibility candidate 9 inhibits gastric cancer and reverses chemoresistance.
    Shang C; Sun L; Zhang J; Zhao B; Chen X; Xu H; Huang B
    Oncotarget; 2017 Feb; 8(9):15393-15398. PubMed ID: 28146436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer.
    Shang C; Guo Y; Zhang J; Huang B
    Cancer Chemother Pharmacol; 2016 May; 77(5):1061-7. PubMed ID: 27056384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of long non-coding RNA ANRIL inhibits the development of multidrug resistance in gastric cancer cells.
    Lan WG; Xu DH; Xu C; Ding CL; Ning FL; Zhou YL; Ma LB; Liu CM; Han X
    Oncol Rep; 2016 Jul; 36(1):263-70. PubMed ID: 27121324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silence of Long Noncoding RNA NEAT1 Inhibits Malignant Biological Behaviors and Chemotherapy Resistance in Gastric Cancer.
    Zhang J; Zhao B; Chen X; Wang Z; Xu H; Huang B
    Pathol Oncol Res; 2018 Jan; 24(1):109-113. PubMed ID: 28401449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. lncRNA PVT1 silencing inhibits gastric cancer cells' progression via enhancing chemosensitivity to paclitaxel.
    Naseri B; Farsad-Akhtar N; Mardi A; Baghbani E; Bornedeli S; Asadi M; Shanehbandi D
    Gene; 2025 Jan; 932():148900. PubMed ID: 39209180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA CASC9 promotes the progression and development of gastric cancer via regulating miR-370/EGFR axis.
    Li C; Zhang J; Zhou Y; Li B
    Dig Liver Dis; 2021 Apr; 53(4):509-516. PubMed ID: 33478874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of lncRNA BNC2-AS1 on the Proliferation, Migration and Invasion of Gastric Cancer Cells.
    Liu C; Yang G; Liu N; Zhou Z; Cao B; Zhou P; Yang B
    Clin Lab; 2018 Oct; 64(11):. PubMed ID: 30549996
    [No Abstract]   [Full Text] [Related]  

  • 8. LncRNA SNHG5 promotes cisplatin resistance in gastric cancer via inhibiting cell apoptosis.
    Li M; Zhang YY; Shang J; Xu YD
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4185-4191. PubMed ID: 31173289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA DANCR accelerates the development of multidrug resistance of gastric cancer.
    Xu YD; Shang J; Li M; Zhang YY
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2794-2802. PubMed ID: 31002130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AP-2α reverses vincristine-induced multidrug resistance of SGC7901 gastric cancer cells by inhibiting the Notch pathway.
    Lian W; Zhang L; Yang L; Chen W
    Apoptosis; 2017 Jul; 22(7):933-941. PubMed ID: 28439677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA CASC9 Suppressed the Apoptosis of Gastric Cancer Cells through Regulating BMI1.
    Fang J; Chen W; Meng XL
    Pathol Oncol Res; 2020 Jan; 26(1):475-482. PubMed ID: 31642035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA cancer susceptibility candidate 9 promotes doxorubicin‑resistant breast cancer by binding to enhancer of zeste homolog 2.
    Jiang B; Li Y; Qu X; Zhu H; Tan Y; Fan Q; Jiang Y; Liao M; Wu X
    Int J Mol Med; 2018 Nov; 42(5):2801-2810. PubMed ID: 30106089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of MDR1 increases the sensitivity to adriamycin in drug resistant gastric cancer cells.
    Zhu CY; Lv YP; Yan DF; Gao FL
    Asian Pac J Cancer Prev; 2013; 14(11):6757-60. PubMed ID: 24377601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA MRUL promotes ABCB1 expression in multidrug-resistant gastric cancer cell sublines.
    Wang Y; Zhang D; Wu K; Zhao Q; Nie Y; Fan D
    Mol Cell Biol; 2014 Sep; 34(17):3182-93. PubMed ID: 24958102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLUT-1 participates in the promotion of LncRNA CASC9 in proliferation and metastasis of laryngeal carcinoma cells.
    Xi J; Wang Y; Liu H
    Gene; 2020 Feb; 726():144194. PubMed ID: 31669650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance.
    Zhang XW; Bu P; Liu L; Zhang XZ; Li J
    Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA LUCAT1 promotes proliferation and invasion in gastric cancer by regulating miR-134-5p/YWHAZ axis.
    Chi J; Liu T; Shi C; Luo H; Wu Z; Xiong B; Liu S; Zeng Y
    Biomed Pharmacother; 2019 Oct; 118():109201. PubMed ID: 31545227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midkine confers Adriamycin resistance in human gastric cancer cells.
    Xu YY; Mao XY; Song YX; Zhao F; Wang ZN; Zhang WX; Xu HM; Jin F
    Tumour Biol; 2012 Oct; 33(5):1543-8. PubMed ID: 22576950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells.
    Zheng H; Wang JJ; Yang XR; Yu YL
    World J Gastroenterol; 2020 Feb; 26(5):499-513. PubMed ID: 32089626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long noncoding RNA CASC9 regulates migration and invasion in esophageal cancer.
    Pan Z; Mao W; Bao Y; Zhang M; Su X; Xu X
    Cancer Med; 2016 Sep; 5(9):2442-7. PubMed ID: 27431358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.